It is known that among all cancer testis antigens, PRAME is in a unique position as it not only is widely expressed in various cancers but also elicits specific cellular immune responses against numerous neoplastic cells, as well as against leukemia progenitor cells, and plays a role in the innate immune response (Al-Khadairi and Decock, 2019). This evidence concerns the gene PRAME and cancer.